Michael P. Fay

机构：Cancer Research And Biostatistics, National Institute of Allergy and Infectious Diseases · ORCID：0000-0002-8643-9625

发表论文 261 篇 · 总被引 21146 次 · h-index 62

代表论文

• Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration (2023 · Nature Communications · 被引 45)
• A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome (2023 · Journal of Clinical Investigation · 被引 43)
• An International, Retrospective Study of Off-Label Biologic Use in the Treatment of Hypereosinophilic Syndromes (2022 · The Journal of Allergy and Clinical Immunology In Practice · 被引 39)
• Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial (2023 · The Lancet Respiratory Medicine · 被引 25)
• Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults (2023 · JAMA Network Open · 被引 23)
• Platelet proteomic profiling reveals potential mediators of immunothrombosis and proteostasis in myeloproliferative neoplasms (2024 · Blood Advances · 被引 21)